A carefully timed first-trimester screening pathway combining NT ultrasound, maternal serum PAPP-A and free beta-hCG to estimate early risk for common chromosomal conditions — interpreted with compassionate counselling by Dr. Kunda Shahane at Mayflower Fetal Medicine & High-Risk Pregnancy Centre.
First trimester combined screening combines two types of information: a specialised NT ultrasound scan and a maternal blood test measuring PAPP-A and free beta-hCG. These results are interpreted together with maternal age, gestational age and pregnancy details to calculate an individual risk estimate for common chromosomal conditions.
The purpose is not to label a pregnancy as “normal” or “abnormal.” The purpose is to identify which pregnancies have a low-risk reassuring pattern, and which pregnancies may need further counselling, NIPT, CVS, amniocentesis or a more detailed follow-up plan.
A good combined screening result depends on correct ultrasound measurement, accurate blood marker interpretation and clear counselling. The table below shows how each part contributes to the final risk estimate.
| Component | What is assessed | Why it matters | Important note |
|---|---|---|---|
| CRL / gestational age | Crown-rump length confirms whether pregnancy is within the valid NT screening window. | Risk calculation depends on exact gestational age, not just LMP dates. | Timing critical |
| NT measurement | Nuchal translucency thickness is measured in a standardised fetal position. | Increased NT may be associated with chromosomal risk, cardiac concerns or other conditions. | Specialist scan |
| Nasal bone and markers | Selected ultrasound markers may be reviewed depending on fetal position and protocol. | Additional markers may refine risk interpretation when technically visible. | Position dependent |
| PAPP-A | Pregnancy-associated plasma protein-A from maternal blood. | Low values may influence chromosomal risk and may also guide closer pregnancy surveillance in selected cases. | Blood marker |
| Free beta-hCG | Hormonal blood marker interpreted with gestational age. | Pattern may contribute to risk calculation for common trisomies. | Blood marker |
| Maternal factors | Age, weight, IVF history, diabetes status, smoking status if relevant, and pregnancy details. | These details make the report personalised rather than a generic age-risk estimate. | Individualised |
| Final risk report | Risk estimate for Trisomy 21, Trisomy 18 and Trisomy 13. | Helps decide whether reassurance, NIPT, CVS or amniocentesis is appropriate. | Screening only |
The most important rule is not to miss the first trimester window. If you are unsure of dates, book early so Dr. Kunda can plan the viability/dating scan, blood test and NT scan in the correct sequence.
Most pregnant women can consider first trimester combined screening if they are within the correct gestational window. It is especially helpful when parents want early information before the anomaly scan.
The result is usually expressed as a risk number, such as 1 in 5000, 1 in 500 or 1 in 50. The number must be interpreted in context — not read with fear and not ignored casually.
Many parents are confused because several tests are available in early pregnancy. Each test answers a different question. Dr. Kunda helps you choose the right pathway instead of ordering tests blindly.
| Test | What it gives | Strength | Limitation |
|---|---|---|---|
| NT scan | Ultrasound-based early fetal assessment and NT measurement. | Visual assessment of early anatomy and markers. | Less complete than combined screening if blood markers are not added. |
| Combined screening | NT + PAPP-A + free beta-hCG + maternal factors. | Balanced first-line screening with ultrasound and biochemical information. | It is still a screening test, not a final diagnosis. |
| NIPT | Cell-free fetal DNA screening from maternal blood. | Higher screening accuracy for common trisomies. | Does not replace ultrasound anatomy assessment or diagnostic testing when needed. |
| CVS / Amniocentesis | Diagnostic sample for fetal chromosomes/genetic testing. | Can confirm or exclude many chromosomal concerns. | Invasive; needs specialist counselling and informed consent. |
The visit is designed to feel organised and calm. Please bring previous reports, medication details and the exact date of your last menstrual period or IVF embryo transfer details.
A high-risk screening result can be emotionally difficult, but it is not the same as a diagnosis. The next step is careful counselling — not panic.
This video from Dr. Kunda Shahane explains when pregnancy ultrasound is usually planned. It is useful for parents trying to understand why first trimester timing matters.
First trimester combined screening is part of a larger early pregnancy care pathway.
The best time to plan is before the NT window closes. Share your LMP or IVF dates with the clinic team so the correct appointment timing can be advised.
Mayflower Fetal Medicine & High-Risk Pregnancy Centre, Dhantoli, Nagpur, provides fetal ultrasound, prenatal diagnosis, fetal echocardiography, Doppler studies, genetic counseling and high-risk pregnancy care under Dr. Kunda Shahane.

Fetal Echocardiography: Detecting Heart Defects before Birth…

High-Risk Pregnancy: How Fetal Medicine Supports Moms…
Surdham Complex, Behind Silver Palace Building, 2nd Lane from Panchsheel Sq., Opp. Yashwant Stadium, Dhantoli Nagpur - 440012
07126692706
whatsapp 8087471244
